← Release of information queue
ROI request — full review
The complete production, assembled for human review before anything is released. What follows is exactly what fulfilment would disclose — and, just as explicitly, what it would withhold and why.
Release requirements — jurisdiction CA
Every requirement of the applicable jurisdiction, evaluated by the validator against this request's actual authorization. The validator can block a release; it can never approve one — the decision below remains yours, and every evaluation is recorded.
| Requirement | Authority | Verdict | Basis |
|---|---|---|---|
| Authorization signed and dated HARD | 45 CFR §164.508(c)(1)(vi) | met | Signed 2026-07-28. |
| Authorization not expired HARD | 45 CFR §164.508(c)(1)(v) | met | Valid through 2027-01-28. |
| Description of information with specificity | 45 CFR §164.508(c)(1)(i) | met | Patient access request under §164.524 — this authorization element does not apply. |
| Right-to-revoke statement present HARD | 45 CFR §164.508(c)(2)(i) | met | Patient access request under §164.524 — this authorization element does not apply. |
| Part 2-specific consent where SUD records are in scope HARD | 42 CFR §2.31 | met | Patient access request under §164.524 — this authorization element does not apply. |
| Authorization meets CMIA form requirements (separate, clearly captioned) | CA Civil Code §56.11 | met | Patient access request under §164.524 — this authorization element does not apply. |
What fulfilment would release
| Record class | Count | Contents |
|---|---|---|
| Demographics | 1 | Name, MRN, DOB, sex, address, payer |
| Conditions | 15 | Localised gingival recession; Chronic pain (finding); Chronic low back pain (finding); … |
| Medications | 6 | 12 HR Hydrocodone Bitartrate 10 MG Extended Release Oral Capsule; 72 HR Fentanyl 0.025 MG/HR Transdermal System; Abuse-Deterrent 12 HR Oxycodone Hydrochloride 10 MG Extended Release Oral Tablet [Oxycontin]; … |
| Encounters | 25 | Visit history with dates, types, providers, facilities |
| Labs & vitals | 59 | Result series with values, units and abnormal flags |
| Clinical notes | 1 | Progress note · full text released |
| Imaging studies | 0 | Modality, body site, report status |
| Claims & billing | 8 | Claims with service lines and adjudication (in scope for this requester type) |
What fulfilment would withhold
| Withheld | Count | Rule |
|---|---|---|
| Psychotherapy notes | 2 | Never released through ROI — separate store, separate authorization lane (45 CFR §164.508(a)(2)). |
| Sensitive — mental_health | 3 | Sensitive category: excluded absent specific consent for this disclosure. |
| Sensitive — sud_part2 | 1 | 42 CFR Part 2: released only with Part 2-specific consent for this disclosure. |
Resolved: fulfilled on Aug 12, 2026
✦ AI Second-pass leakage review
Classification cleared this production set at the door; the reviewer is the second pass — it reads the full text of every cleared document hunting for sensitive content a classifier can miss: a Part 2 mention buried in an ordinary note, a psychotherapy reference in a discharge summary. It quotes every risky line. The release decision stays yours.